Pharmacology Impact Factor
Pharmacology which is the medicine and biology branch deals with drug action studies. More specifically,
pharmacology is the study of the interactions between a living organism and chemicals that cause normal or abnormal biochemical functions. High-impact
journals are those which are considered highly influential in their fields. Journal
impact factor provides a quantitative evaluation tool for the grading, evaluation, sorting, and comparison of similar journals.It reflects the average number of citations to recent
articles published in science and
social science journals in a given year or period, and is often used as a proxy for a journal's relative importance within its field. It is first devised by the Institute for Scientific
Information founder, Eugene Garfield. A journal's
impact factor is assessed by dividing the number of current year citations into the source items that were published in that journal over the previous two years.
High Impact List of Articles
-
The effect of ulinastatin combined with bone marrow mesenchymal stem cells on directional repairing of liver ischemia and reperfusion injury in rats
Weixing Wang, Zhixiong Wu, Xidong Wang & Lianjie Liu
Research Article: Pharmaceutical Bioprocessing
-
The effect of ulinastatin combined with bone marrow mesenchymal stem cells on directional repairing of liver ischemia and reperfusion injury in rats
Weixing Wang, Zhixiong Wu, Xidong Wang & Lianjie Liu
Research Article: Pharmaceutical Bioprocessing
-
Adherence to antihypertensive medication in the older hypertensive patients: the role of blood pressure measurement assistance
Elena N Nalotova, Michail M Alesinskiy, Alexander E. Berezin & Sergey V Nalotov
Research Article: Pharmaceutical Bioprocessing
-
Adherence to antihypertensive medication in the older hypertensive patients: the role of blood pressure measurement assistance
Elena N Nalotova, Michail M Alesinskiy, Alexander E. Berezin & Sergey V Nalotov
Research Article: Pharmaceutical Bioprocessing
-
Limitless starting materials for large-scale manufacture of MSCs - what does the future hold?
Kilian Kelly
Editorial: Pharmaceutical Bioprocessing
-
Limitless starting materials for large-scale manufacture of MSCs - what does the future hold?
Kilian Kelly
Editorial: Pharmaceutical Bioprocessing
-
Toward a two-tier process-development paradigm: prototype versus commercial biomanufacturing
Jesus Zurdo
Commentary: Pharmaceutical Bioprocessing
-
Toward a two-tier process-development paradigm: prototype versus commercial biomanufacturing
Jesus Zurdo
Commentary: Pharmaceutical Bioprocessing
-
Near-infrared spectroscopy in upstream bioprocesses
Marek Hoehse*, Jose Alves Rausch, Andreas Prediger, Patricia Roch and Christian Grimm
Review Article: Pharmaceutical Bioprocessing
-
Near-infrared spectroscopy in upstream bioprocesses
Marek Hoehse*, Jose Alves Rausch, Andreas Prediger, Patricia Roch and Christian Grimm
Review Article: Pharmaceutical Bioprocessing
Relevant Topics in Clinical